Guggenheim Capital, LLC Managers »

Crispr Therapeutics shares owned by Guggenheim Capital, LLC Managers

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Guggenheim Capital, LLC Managers from 13F filings

Historical chart of Guggenheim Capital, LLC Managers investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Guggenheim Capital, LLC Managers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Guggenheim Capital, LLC Managers

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.2M 36k 62.60
2023-09-30 $2.3M 50k 45.39
2023-06-30 $3.9M 70k 56.14
2023-03-31 $3.4M 75k 45.23
2022-12-31 $3.3M 82k 40.65
2022-09-30 $5.1M 78k 65.35
2022-06-30 $4.5M 74k 60.75
2022-03-31 $4.8M 76k 62.76
2021-12-31 $6.5M 86k 75.79
2021-09-30 $7.3M 65k 111.92
2021-06-30 $5.1M 32k 162.31
2021-03-31 $3.8M 31k 121.84
2020-12-31 $2.9M 19k 153.10